{
  "abstract": "This cohort study evaluates early treatment trends of oral semaglutide among adults eligible for obesity management medications following its approval for obesity.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia",
    "The Center for Health AI and Synthesis of Evidence, University of Pennsylvania, Philadelphia",
    "Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia",
    "The Graduate Group in Applied Mathematics and Computational Science, School of Arts and Sciences, University of Pennsylvania, Philadelphia",
    "Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia",
    "Leonard Davis Institute of Health Economics, Philadelphia, Pennsylvania",
    "Wharton School, University of Pennsylvania, Philadelphia",
    "Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia",
    "Penn Medicine Center for Evidence-based Practice, Philadelphia, Pennsylvania"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 5,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Yuqing Lei"
    },
    {
      "affs": [
        0,
        1,
        2
      ],
      "name": "Huilin Tang"
    },
    {
      "affs": [
        1,
        3
      ],
      "name": "Xinyao Jian"
    },
    {
      "affs": [
        4,
        5,
        6,
        7
      ],
      "name": "David A. Asch"
    },
    {
      "affs": [
        0,
        1,
        3,
        5,
        8
      ],
      "name": "Yong Chen"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/6ep9z0kzvbwfq.bib",
  "cited_by": 0,
  "doi": "10.1001/jamanetworkopen.2026.37779",
  "fulltext_url": null,
  "id": "6ep9z0kzvbwfq",
  "issns": [
    "2574-3805"
  ],
  "landing_url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854937",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2736|Pharmacology and Obesity Treatment"
    ]
  ],
  "openalex": "W7220833880",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-07",
  "publisher": "American Medical Association (AMA)",
  "ris": "https://research.draconitic.com/paper/6ep9z0kzvbwfq.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:19:46Z",
      "native_id": "10.1001/jamanetworkopen.2026.37779",
      "source": "crossref",
      "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854937"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2736|Pharmacology and Obesity Treatment",
      "subfield": "pharmacology-toxicology"
    }
  ],
  "title": "Early Adoption and Diffusion of Oral Semaglutide in US Adults With Obesity",
  "title_text": "Early Adoption and Diffusion of Oral Semaglutide in US Adults With Obesity",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:19:46Z",
  "url": "https://research.draconitic.com/paper/6ep9z0kzvbwfq",
  "venue": "JAMA Network Open",
  "versions": []
}